Amgen
Amgen and Novartis start cancer immunotherapy push
January 7, 2015Research and Development, Sales and Marketing Amgen, Caribou Biosciences, Intellia Therapeutics, Novartis, kite pharma
Amgen and Novartis have launched new licensing agreements with biotech companies that they hope will lead to the development of …
Novartis biosimilar rivals Amgen offering
December 9, 2014Sales and Marketing Amgen, Neupogen, Novartis, Sandoz, filgrastim, zarzio
An investigational biosimilar by Novartis’ generic pharma arm Sandoz has been found to have comparable safety and efficacy readings to …
Sanofi showcases alirocumab at AHA
November 20, 2014Sales and Marketing Amgen, PCSK9, Regeneron, Sanofi, aha, alirocumab, evolocumab
Sanofi and Regeneron released a battery of new Phase III data on their PCSK9 inhibitor alirocumab this week, reinforcing the …
Amgen submits next gen cholesterol drug
August 29, 2014Sales and Marketing Amgen, FDA, PCSK9, Regeneron, Sanofi, statins
Amgen has put itself in pole position in the race to market the next generation of injectable statins known as …
Amgen cancer drug fails key test
August 14, 2014Sales and Marketing Amgen, Cancer, Kyprolis, myeloma
Amgen’s new rare cancer drug has failed in a late-stage trial just a year after the US biotech spent $10.4 …
Amgen to wield axe on 2,900 jobs
July 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Enbrel, Prolia, job cuts
Amgen has announced this morning that it will make swingeing cuts in the US over the next two years as …
FDA breakthrough for Amgen
July 2, 2014Research and Development, Sales and Marketing Amgen, BiTE antibody blinatumomab, FDA, all, leukaemia
Amgen has taken a major step down the road to getting its investigational cancer drug blinatumomab onto the market after …
Amgen names senior VP of Business Development
March 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, David Piacquad
Amgen has confirmed the appointment of David Piacquad to the new position of senior vice president of its Business Development …
Success for Amgen’s ‘bad’ cholesterol injection
March 18, 2014Research and Development, Sales and Marketing Amgen, LDL, PCSK9, evolocumab, hofh, tesla
An investigational PCSK9 Inhibitor from Amgen has reduced LDL-C (‘bad’ cholesterol) in patients suffering from a rare genetic disorder in …
Amgen melanoma vaccine shrinks tumours
March 17, 2014Research and Development, Sales and Marketing Amgen, Cancer, Yervoy, melanoma, t-vec
Amgen’s investigational cancer vaccine T-vec has managed to shrink the size of advanced melanoma tumours in a late-stage trial. The …
ABPI worried about Prolia use
March 10, 2014Sales and Marketing ABPI, Amgen, NHS, Xgeva
The ABPI has once again voiced concern that NHS patients in some areas of England are not getting access to …
Amgen commits $2.5 million to biotech educational grants
November 12, 2013Research and Development, Sales and Marketing Amgen, EDC, Onyx, biotech, stem
The Amgen Foundation has announced $2.5 million in new grants for its science programme to aid schools in the US …
Amgen promotes two senior executives
October 29, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen
Amgen has promoted two senior executives as Brian McNamee becomes executive vice president and Stuart Tross senior vice president. McNamee …
Amgen to open Chinese R&D centre
September 26, 2013Research and Development, Sales and Marketing Amgen, China, R&D, Zhejiang
Amgen has signalled its intention to expand in China by announcing the opening of an R&D centre which will focus …
Amgen/Cytokinetics heart drug fails in clinical trial
September 3, 2013Research and Development, Sales and Marketing Amgen, Novartis, cytokinetics, omecamtiv mecarbil
A new heart failure drug by Amgen and Cytokinetics has fallen short of its primary endpoint in a Phase II …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
